Navigation Links
Symmetry Medical Reports Record Second Quarter 2008 Revenue of $109.8 Million
Date:8/6/2008

8. Gross margin for the second quarter of 2008 was unfavorably impacted by negative gross margin incurred at the Company's Sheffield, UK operating unit.

Selling, general and administrative expenses were $14.9 million for the second quarter 2008, compared to $8.0 million in the second quarter 2007. The year-over-year increase was primarily driven by the inclusion of $2.5 million of ongoing expense from the Company's recent acquisitions, $2.5 million increase in employee related expense including non-cash stock based compensation and $1.4 million in professional fees and expenses incurred from the review of accounting irregularities at the Company's Sheffield, UK operating unit. Selling, general and administrative expenses were also higher due to ongoing initiatives to improve management oversight and operational performance at the Company's Sheffield, UK operating unit.

Operating income for the second quarter of 2008 was $12.5 million, up 86.8% from $6.7 million for the second quarter 2007 and up 30.6% from $9.6 million in the first quarter 2008. Operating margin for the second quarter 2008 was 11.4%, an increase from 9.6% and 9.4% for the second quarter 2007 and the first quarter 2008, respectively.

The second quarter 2008 included a non-cash gain of $1.4 million from an increase in the fair value of the Company's interest rate derivatives due to higher interest rates, compared to a non-cash gain of $0.7 million in the second quarter 2007.

Income tax expense for the second quarter 2008 was $4.9 million, compared to $1.4 million for the second quarter of 2007. The Company's overall corporate tax rate in the second quarter increased over the second quarter of 2007 due to a net loss at its Sheffield, UK facility, which carries a lower tax rate than the U.S. statutory rate. The Company also incurred a $0.7 million tax expense related to Symmetry's ongoing assessment of reserves for uncertain tax provisions as required by FASB FIN48.

Ne
'/>"/>

SOURCE Symmetry Medical Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Symmetry Medical to Report Second Quarter 2008 Financial Results on August 6, 2008
2. Symmetry Medical Reports Record First Quarter 2008 Revenue of $101.9 Million
3. Symmetry Medical to Report First Quarter 2008 Financial Results on June 24, 2008
4. Symmetry Medical Reports Full Year 2007 Financial Results
5. Symmetry Medical Delays 10-K Filing to Complete Review
6. Symmetry Medical to Expand Malaysian Operations
7. Facial asymmetry persists despite surgery to correct congenital deformity
8. Symmetry Medical to Provide Fourth Quarter 2007 General Business Update on February 14, 2008
9. Symmetry Medical Completes Acquisition of DePuy Orthopaedic Instrument Facility
10. Symmetry Medical Provides Update of Previously Disclosed Accounting Review at Sheffield, UK Operating Unit
11. Symmetry Medical Appoints John Hynes Chief Operating Officer, Europe
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:New study finds low rate of injuries at overnight summer camp 2Health News:DNA Test May Detect Immune Disorder in Infants 2Health News:Soy Beneficial for Breast Cancer Survivors: Study 2Health News:Soy Beneficial for Breast Cancer Survivors: Study 3Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 2Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 3Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 4Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 5Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 6Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 7Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 8Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 9Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 10Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 11Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 12Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 13Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 14Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 15Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 16Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 17Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 18Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 19Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 20Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 21Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 2Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 3Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 4Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 5Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 6
Breaking Medicine Technology:Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 2Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 3Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 4Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 5Remote Technologies Improve Patient Care, Viable Alternative to Intensivist Shortage 2Remote Technologies Improve Patient Care, Viable Alternative to Intensivist Shortage 3Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly 2Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly 3South Florida Law Firm Steinger Iscoe 26amp 3B Greene Offers Around the Clock Free Legal Advice to Broward General Contaminated IV Patients 59072 1South Florida Law Firm Steinger Iscoe 26amp 3B Greene Offers Around the Clock Free Legal Advice to Broward General Contaminated IV Patients 59072 2South Florida Law Firm Steinger Iscoe 26amp 3B Greene Offers Around the Clock Free Legal Advice to Broward General Contaminated IV Patients 59072 3South Florida Law Firm Steinger Iscoe 26amp 3B Greene Offers Around the Clock Free Legal Advice to Broward General Contaminated IV Patients 59072 4National Jewish Health Developing a Molecular Roadmap for Chronic Lung Diseases 59067 1National Jewish Health Developing a Molecular Roadmap for Chronic Lung Diseases 59067 2Philadelphia Insurance Companies and the Big 5 Battle Cancer on the Court 59062 1Philadelphia Insurance Companies and the Big 5 Battle Cancer on the Court 59062 2